Asia-Pacific diagnostic tests market is projected to register a substantial CAGR of 9.8% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Market Segmentation:
Asia-Pacific Diagnostic Tests Market, By Type (Glucose Test, Infectious Diseases Test, Cytology Test, CBC Test, Blood Culture Test, Syphilis Test, Urea Test, C-Reactive Protein Test, Antigen Test, HBA1C Test, Pregnancy Test, Lipid Profile Test, Electrolytes Test, Liver Function Test, Stool Helicobacter Pylori Test, Calcium Test, Crossmatch Test, Thyroid Function Test, Stool Microscopy Test, Urine Microscopy Test, Unit Packed RBCS Test, ESR Test and Others Test), Solutions (Services and Products), Technology (Immunoassay-Based, PCR-Based, Next Gene Sequencing, Spectroscopy-Based, Chromatography-Based, Microfluidics, Substrate Technology and Others), Mode of Testing (Prescription-Based Testing and OTC Testing), Approach (Molecular Diagnostic Instrument, In-Vitro Diagnostic Instrument and Point Of Care Testing Instrument), Sample Type (Urine, Saliva, Blood, Hair, Sweat and Others), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Odontology and Others), Testing Type (Biochemistry, Haematology, Microbiology, Histopathology and Others), Age (Pediatric, Adult and Geriatric), End User (Hospitals, Diagnostic Center, Research Labs & Institutes, Research Institute, Homecare, Blood Banks, Specialty Clinics, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tenders, Retail Sales and Online Sales), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Rest of Asia-Pacific) Industry Trends & Forecast to 2027
Some of the major factors contributing to the growth of the Asia-Pacific diagnostic tests market are:
• Increasing prevalence of chronic diseases
• Rising number of IVD tests conducted across the globe
Market Players
The key market players for Asia-Pacific diagnostic tests market are listed below:
• F. Hoffmann-La Roche Ltd
• Abbott
• Danaher
• Siemens Healthcare GmbH
• bioMérieux SA
• Thermo Fisher Scientific Inc.
• WerfenLife, S.A.
• Bio-Rad Laboratories, Inc.
• PerkinElmer Inc.
• QIAGEN
• Illumina, Inc.
• Quidel Corporation
• BD
• ARKRAY USA, Inc.
• DiaSorin S.p.a.
• Grifols, S.A.
• Sannuo biosensor Ltd.
• Nova Biomedical
• STRECK
• BODITECH MED INC.
• EKF DIAGNOSTICS HOLDINGS PLC
• Chembio Diagnostic Systems, Inc.
• Medixbiochemica
• NanoEnTek Inc.
• ACON Laboratories, Inc.
• Biohit Oyj
• HUMASIS